Johns Hopkins HIV Guide
Doxorubicin Liposomal
INDICATIONS
FDA
FDA
- Treatment of AIDS-related Kaposi’s sarcoma (KS)
- Ovarian cancer
- Multiple myeloma
- Ovarian cancer (advanced)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Breast cancer (metastatic)
- Cutaneous T-cell lymphomas
- Hodgkin’s lymphoma (salvage treatment)
- Soft tissue sarcoma (advanced)
- Uterine sarcoma (advanced or recurrent)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 5, 2017
Citation
Smith, Janessa, and Paul A Pham. "Doxorubicin Liposomal." Johns Hopkins HIV Guide, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545058/2/Doxorubicin_Liposomal.
Smith J, Pham PA. Doxorubicin Liposomal. Johns Hopkins HIV Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545058/2/Doxorubicin_Liposomal. Accessed June 3, 2023.
Smith, J., & Pham, P. A. (2017). Doxorubicin Liposomal. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545058/2/Doxorubicin_Liposomal
Smith J, Pham PA. Doxorubicin Liposomal [Internet]. In: Johns Hopkins HIV Guide. ; 2017. [cited 2023 June 03]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545058/2/Doxorubicin_Liposomal.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Doxorubicin Liposomal
ID - 545058
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/01/05/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545058/2/Doxorubicin_Liposomal
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
